Aug 9, 2020

Bevacizumab for pediatric radiation necrosis

Neuro-oncology practice
Lorena V Baroni, Daniel Alderete, Palma Solano-Paez, Carlos Rugilo, Candela Freytes, Suzanne Laughlin, Adriana Fonseca, Ute Bartels, Uri Tabori, Eric Bouffet, Annie Huang, Normand Laperriere, Derek S Tsang, David Sumerauer, Martin Kyncl, Barbora Ondrová, Vajiranee S Malalasekera, Jordan R Hansford, Michal Zápotocký, Vijay Ramaswamy
CONCLUSIONS: Bevacizumab appears to be effective and well-tolerated in children as treatment for symptomatic radiation necrosis and warrants more robust study in the context of controlled clinical trials.